EW
Edwards Lifesciences Corp
- PER (TTM)
- 43.22
- PER (Forward)
- 23.78
- EPS (TTM)
- -
- EPS (Forward)
- -
- PBR
- 4.49
- 시가총액
- 46.04B
- 배당수익률
- -
- 베타
- 0.87
- 1개월 수익률
- 1.02%
- 3개월 수익률
- 1.59%
- 6개월 수익률
- -3.48%
- 1년 수익률
- 6.56%
- 2년 수익률
- -
- 5일 평균거래량
- 3807660
- 60일 평균거래량
- 4976353
- 1년 평균거래량
- 4418414
- 5d/60d 거래량 비율
- 0.77×
- 60d/1y 거래량 비율
- 1.13×
- 변동성(60일, 연환산)
- 29.52%
- BB 스퀴즈 스코어
- 1.14
- SMA50 비율
- 0.97
- SMA200 비율
- 0.98
- RSI (14)
- 44
- 20일 수렴도
- 0.02
- 52주 최고
- 87.18
- 52주 최저
- 72.65
- 고점 대비
- -8.28%
- 저점 대비
- 10.06%
펀더멘털 갱신: 2026-05-10T08:52:40+00:00 · 시세 갱신: 2026-05-10T06:32:16+00:00
회사 정보
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.